CTI BioPharma Corp. (CTIC) News

CTI BioPharma Corp. (CTIC): $9.09

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

C

Add CTIC to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#124 of 385

in industry

Filter CTIC News Items

CTIC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

CTIC News Highlights

  • For CTIC, its 30 day story count is now at 2.
  • Over the past 7 days, the trend for CTIC's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • TG are the most mentioned tickers in articles about CTIC.

Latest CTIC News From Around the Web

Below are the latest news stories about CTI BIOPHARMA CORP that investors may wish to consider to help them evaluate CTIC as an investment opportunity.

Top Small-Cap Stocks for June 2023

Biggest movers include Prometheus, TG Therapeutics, and Akero Therapeutics, all more than quadrupling in price in the last year while the Russell 2000 Index stays nearly unchanged.

Yahoo | June 6, 2023

CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders

CTI BioPharma Corp. (Nasdaq: CTIC) ("CTI"), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that it has cancelled the 2023 Annual Meeting of Stockholders (the "Annual Meeting") which was scheduled for June 21, 2023, and has withdrawn the proposals to have been submitted to stockholders at the Annual Meeting.

Yahoo | May 30, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

It's time for another dive into the biggest pre-market stock movers as we see what shares are on rising and falling on Tuesday!

William White on InvestorPlace | May 10, 2023

Why Is Babylon (BBLN) Stock Down 57% Today?

Babylon (BBLN) stock is falling on Wednesday after the health services company revealed earnings and a plan to go private.

William White on InvestorPlace | May 10, 2023

Why Is CTI BioPharma (CTIC) Stock Up 85% Today?

CTI BioPharma (CTIC) stock is taking off on Wednesday after the company announced a major $1.7 billion acquisition deal with Sobi.

William White on InvestorPlace | May 10, 2023

SYNH Stock Alert: The $7 Billion Reason Syneos Health Is Up Today

Syneos Health (SYNH) stock is on the rise Wednesday as investors react to news of a $7.1 billion acquisition deal with a group of investors.

William White on InvestorPlace | May 10, 2023

Why Is SeaStar Medical (ICU) Stock Down 32% Today?

SeaStar Medical (ICU) stock is falling on Wednesday after the medical technology company got a rejection letter from the FDA.

William White on InvestorPlace | May 10, 2023

Why Shares of CTI BioPharma Are Soaring Wednesday

What happened Shares of CTI BioPharma (NASDAQ: CTIC) were up more than 80% early Wednesday after the company announced it was getting bought out for $1.7 billion by Swedish Orphan Biovitrum AB (OTC: BIOVF), also known as SOBI.

Yahoo | May 10, 2023

European Swedish Orphan Biovitrum To Acquire CTI BioPharma For $1.7B

Swedish Orphan Biovitrum AB (OTC: BIOVF) has agreed to acquire CTI BioPharma (NASDAQ: CTIC) for $9.10 per share of common stock in an all-cash transaction, representing an implied equity value of approximately $1.7 billion. The transaction price represents an 89% premium to CTI's closing share price on May 9, 2023, and a 95% premium to its 30-trading day volume-weighted average price of $4.67. The transaction will diversify Sobi's portfolio of hematology medicines through CTI's lead product, Von

Yahoo | May 10, 2023

CTI BioPharma Stock Soars After Agreeing to $1.7 Billion Sale. Biotech Deals Keep Coming.

Swedish Orphan Biovitrum will buy CTI for $9.10 a share as it looks to expand its rare hematology portfolio.

Yahoo | May 10, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!